Selt, Florian http://orcid.org/0000-0001-9717-6712
van Tilburg, Cornelis M.
Bison, Brigitte
Sievers, Philipp
Harting, Inga
Ecker, Jonas
Pajtler, Kristian W.
Sahm, Felix
Bahr, Annabelle
Simon, Michèle
Jones, David T. W.
Well, Lennart
Mautner, Victor-Felix
Capper, David
Hernáiz Driever, Pablo
Gnekow, Astrid
Pfister, Stefan M.
Witt, Olaf
Milde, Till
Funding for this research was provided by:
Brain Tumour Charity (GN-000382, GN-000382, GN-000382, GN-000382)
PLGA Fund of Pediatric Brain Tumor Foundation
Deutsche Kinderkrebsstiftung
Verein für krebskranke Kinder Odenwald e.V.
DKTK German Cancer Consortium
Deutsches Krebsforschungszentrum (DKFZ)
Article History
Received: 2 August 2020
Accepted: 29 September 2020
First Online: 7 October 2020
Compliance with ethical standards
:
: CVT discloses advisory roles for Bayer and Novartis. PHD discloses advisory roles for Novartis. OW discloses advisory roles for Novartis, Roche, Astra Zeneca, BMS, and Janssen.
: Consent for data collection was obtained prior to inclusion in the clinical and diagnostic studies mentioned above.
: Consent for publication was obtained by inclusion in the clinical and diagnostic studies mentioned above.
: Patients were included in clinical and/or diagnostic studies, either the SIOP-LGG-2004 trial (NCT00276640), the LGG registry or PTT2.0 (NCT-2016-0414; DRKS00011707). Ethics approvals of the respective studies apply.